Veracyte, Inc. (VCYT)
24.59
-0.45
(-1.80%)
USD |
NASDAQ |
Nov 20, 10:46
Veracyte Free Cash Flow : 161.95M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 161.95M |
| June 30, 2026 | 165.99M |
| March 31, 2026 | 155.34M |
| December 31, 2025 | 126.63M |
| September 30, 2025 | 98.21M |
| June 30, 2025 | 83.97M |
| March 31, 2025 | 78.45M |
| December 31, 2024 | 63.81M |
| September 30, 2024 | 56.48M |
| June 30, 2024 | 40.13M |
| March 31, 2024 | 26.33M |
| December 31, 2023 | 34.26M |
| September 30, 2023 | 29.08M |
| June 30, 2023 | 23.02M |
| March 31, 2023 | 7.146M |
| December 31, 2022 | -1.014M |
| September 30, 2022 | -1.281M |
| June 30, 2022 | -9.798M |
| March 31, 2022 | -6.565M |
| December 31, 2021 | -37.00M |
| September 30, 2021 | -43.23M |
| June 30, 2021 | -38.91M |
| March 31, 2021 | -48.34M |
| December 31, 2020 | -12.55M |
| September 30, 2020 | -13.23M |
| Date | Value |
|---|---|
| June 30, 2020 | -16.14M |
| March 31, 2020 | -10.18M |
| December 31, 2019 | -5.988M |
| September 30, 2019 | -8.358M |
| June 30, 2019 | -9.012M |
| March 31, 2019 | -9.531M |
| December 31, 2018 | -15.40M |
| September 30, 2018 | -19.83M |
| June 30, 2018 | -23.22M |
| March 31, 2018 | -24.61M |
| December 31, 2017 | -25.67M |
| September 30, 2017 | -24.24M |
| June 30, 2017 | -26.02M |
| March 31, 2017 | -29.44M |
| December 31, 2016 | -32.19M |
| September 30, 2016 | -34.53M |
| June 30, 2016 | -31.84M |
| March 31, 2016 | -35.20M |
| December 31, 2015 | -33.13M |
| September 30, 2015 | -35.08M |
| June 30, 2015 | -37.27M |
| March 31, 2015 | -32.15M |
| December 31, 2014 | -29.66M |
| September 30, 2014 | -24.26M |
| June 30, 2014 | -22.50M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Teleflex, Inc. | 388.23M |
| West Pharmaceutical Services, Inc. | 453.40M |
| Globus Medical, Inc. | 766.47M |
| Illumina, Inc. | 637.00M |
| Inspire Medical Systems, Inc. | 97.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 40.26M |
| Cash from Investing (Quarterly) | -139.47M |
| Cash from Financing (Quarterly) | -0.479M |
| Free Cash Flow Per Share (Quarterly) | 0.4581 |
| Free Cash Flow to Equity (Quarterly) | 37.30M |
| Free Cash Flow to Firm (Quarterly) | 37.92M |
| Free Cash Flow Yield | 8.17% |